09:08 AM EDT, 09/18/2025 (MT Newswires) -- ATAI Life Sciences ( ATAI ) said Thursday it was awarded a multi-year, milestone-driven grant worth up to $11.4 million by the National Institute on Drug Abuse, under the National Institutes of Health.

The grant will provide non-dilutive funding to advance Atai Life Sciences' ( ATAI ) 5-HT2A/2C receptor agonist program, which aims to develop novel compounds that will modulate serotonin receptors implicated in addiction, the company said.

Shares of the company were up nearly 3% in recent Thursday premarket activity.